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PURPOSE. Vogt–Koyanagi–Harada (VKH) disease is a systemic autoimmune disorder that affects
organs with melanocytes. The sunset glow fundus (SGF) in VKH disease was evaluated with
polarization-sensitive optical coherence tomography (PS-OCT).
METHODS. The study involved 28 eyes from 14 patients with chronic VKH disease, 21 eyes
from 21 age-matched controls, and 22 eyes from 22 high-myopic patients with a tessellated
fundus. VKH eyes were grouped into sunset or non-sunset groups on the basis of color fundus
images. The presence of melanin in the choroid was determined by using the degree of
polarization uniformity (DOPU) obtained by PS-OCT. The sunset glow index (SGI) was
calculated by using color fundus images. Presence of an SGF was evaluated by using DOPU,
SGI, subfoveal choroidal thicknesses, near-infrared images, and autofluorescence images at
488 nm (SW-AF) and 785 nm (NIR-AF).
RESULTS. There were 16 eyes in the sunset group and 12 eyes in the non-sunset group. For all
eyes in the sunset group, the disappearance of choroidal melanin was clearly detected with
PS-OCT. Percentage areas of low DOPU in the choroidal interstitial stroma of the sunset group
were significantly lower than those of other groups and showed no overlap with other
groups. The distribution of choroidal thicknesses and SGI in the sunset group substantially
overlapped with other groups. The subjective analyses of the sunset and non-sunset groups,
using near infrared, SW-AF, or NIR-AF, showed substantial inconsistencies with the PS-OCT
results.
CONCLUSIONS. PS-OCT provides an in vivo objective evaluation of choroidal melanin loss of the
SGF in chronic VKH disease.
Keywords: polarization, melanocyte, Vogt-Koyanagi-Harada disease, optical coherence
tomography
Vogt–Koyanagi–Harada (VKH) disease is a systemic autoim-mune disorder that affects organs with melanocytes,
including the eye, meninges, skin, and inner ear.1 The clinical
course of VKH disease follows four phases: prodromal, uveitis,
convalescent, and recurrent/chronic.1 In the convalescent or
recurrent/chronic stage, depigmentation of the choroid results
from choroidal melanocyte damage2,3 and the fundus shows
bright orange discoloration. This clinical finding is known as a
‘‘sunset glow fundus’’ (SGF).1
SGF is highly specific to VKH disease and is identified as an
important finding in the Revised Diagnostic Criteria of VKH
disease.4 An association of SGF appearance with the severity of
meningitis and chronic ocular inflammation has been report-
ed.5,6 In some cases, changes in an SGF develop a few years
after onset of VKH disease, without clinically significant
intraocular inflammatory findings.7,8 This delayed development
is considered to result from the persistence of subclinical
choroidal inflammation. SGF represents the natural course of
VKH resulting from insufficient treatment, so accurate diagno-
sis of an SGF is important for the clinical management of this
disorder.
Diagnosis of an SGF is usually based on subjective evaluation
of color fundus (CF) images.9 Given this subjective evaluation,
‘‘sunset glow fundus’’ is a descriptive and somewhat subjective
clinical term, despite its clinical importance, and this uncer-
tainty can cause difficulty in diagnosing an SGF.10 SGF might be
confounded with the normally hypopigmented fundus of some
Caucasian individuals.9 Suzuki7 has proposed the use of the
sunset glow index (SGI), involving an objective evaluation of
color balance in scanned CF images and reported its usefulness
in evaluating the severity of the SGF. However, a lack of further
research meant this method was rarely used in clinical studies
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of VKH disease. Another possible diagnostic method involves
choroidal thickness measurements. Some studies show a
decrease in choroidal thickness with an SGF,11,12 but these
studies do not correlate the extent and severity of SGF
appearance with choroidal thickness.
Polarization-sensitive optical coherence tomography (PS-
OCT) is a functional extension of OCT technology that uses the
polarization properties to acquire three-dimensional (3D)
retinal and choroidal information.13 Multiple scattered light
from melanin in tissue induces depolarization, which is found
in melanin-containing structures such as the retinal pigment
epithelium (RPE) and choroidal melanocytes.14–16 PS-OCT
provides 3D information about melanin distribution in the
retina and choroid and might be useful for the objective
evaluation of the disappearance of choroidal melanocytes in an
SGF. In this study, we evaluated the pathologic condition of
choroidal melanocytes in an SGF by using PS-OCT and
compared the PS-OCT findings with other multimodal imaging
modalities.
METHODS
Participants
This cross-sectional study was performed according to the
tenets of the Declaration of Helsinki. This study was approved
by the institutional review board of Tokyo Medical University
and was registered in a public database (UMIN000026307;
http://www.umin.ac.jp/ctr/index-j.htm). The nature of the
current study and the implications of participating in this
research were explained to all study candidates and written
informed consent was obtained from each participant before
any study procedures or examinations were performed. Eyes
with severe cataract or other eye diseases that could
compromise the image quality were excluded.
We examined 28 eyes from 14 Japanese patients (8 males, 6
females; age range, 39–82 years; mean age, 60.7 years) with a
chronic stage of VKH disease (Table). The diagnosis of VKH
disease was based on the revised criteria proposed by the
International Nomenclature Committee.4 Mean duration from
the initial onset was 56.4 months (range, 13–300 months).
Among the patient cohort, 10 eyes from five patients were in
the remission period of the chronic/recurrence phase and
another 18 eyes from nine patients were in the convalescent
phase without recurrence. Twelve participants were initially
treated with 6 to 10 mg intravenous betamethasone for 3 to 13
days followed by oral prednisolone. For two other patients
(Table, cases 13 and 14), exact dosages and durations of initial
therapies were not available because these patients were
referred to our institute for further follow-up. Two eyes from
one patient (Table, case 14) received cataract surgery with
intraocular lens implantation. The mean spherical equivalent
refractive error was2.1 diopters (D) (range,7.0 toþ0.25 D).
The mean axial length was 24.2 mm (range, 23.0–26.3 mm).
For the age-matched control group, we evaluated 21 eyes
from 21 healthy Japanese participants (17 males, 4 females; age
range, 30–88 years; mean age, 57.0 years). Exclusion criteria
for the control group were a history of intraocular surgery,
retinal and or choroidal pathology, or glaucoma. The ages of
the control group were not significantly different from those of
the VKH disease patients (P ¼ 0.53; Mann-Whitney U test). In
the control group, the right eye was evaluated in 17
participants and the left eye was evaluated in 4 participants.
The mean spherical equivalent refractive error was 2.5 D
(range,7.50 toþ2.25 D). The mean axial length was 24.5 mm
(range, 23.1–26.5 mm).
We evaluated 22 eyes from 22 Japanese patients with high
myopia and tessellated fundus (4 males, 18 females; age range,
18–77 years; mean age, 54.2 years [tessellated fundus group]).
In this group, the right eye was evaluated in 10 patients and
the left eye was evaluated in 12 patients. Seven eyes received
cataract surgery with intraocular lens implantation. The mean
axial length was 29.9 mm (range, 27.1–33.3 mm) and the mean
spherical equivalent refractive error was 11.9 D (range, 3.0
to 25.5 D). The ages of the high-myopia group were not
significantly different from those of patients with VKH disease
(P ¼ 0.43; Mann-Whitney U test).
Polarization-Sensitive Optical Coherence
Tomography Imaging
A detailed description of the prototype PS-OCT system, built by
the Computational Optic Group at the University of Tsukuba,
has been previously reported.17,18 This PS-OCT system is a
multifunctional Jones-matrix OCT, using a swept-source laser
with a central wavelength of 1048 nm. The depth range of
each B-scan image was 2.1 mm and the depth resolution in
tissue was 6.6 lm. The axial scan speed was 100,000 A-scans/s.
A raster scanning protocol with 512 A-lines 3 256 B-scans
covering a 6.0 3 6.0-mm region on the retina was used for
volumetric scans and the acquisition speed of each volumetric
measurement was 6.6 s/vol. For the PS-OCT measurements, B-
scan measurements were repeated four times at a single
location. The degree of polarization uniformity (DOPU) was
TABLE. Summary of Patients With Vogt–Koyanagi–Harada Disease
Case Sex Age, y Classification with CF Duration, mo Phase in VKH Disease Initial Therapy
1 F 82 Non-sunset 15 Convalescent phase BTM 8 mg 3 7 d
2 F 82 Non-sunset 19 Convalescent phase BTM 6 mg 3 3 d
3 F 69 Non-sunset 35 Chronic/recurrence phase BTM 8 mg 3 13 d
4 M 39 Non-sunset 39 Convalescent phase BTM 8 mg 3 8 d
5 F 52 Non-sunset 42 Convalescent phase BTM 8 mg 3 7 d
6 F 45 Non-sunset 52 Convalescent phase BTM 10 mg 3 7 d
7 M 45 Sunset 13 Chronic/recurrence phase BTM 8 mg 3 9 d
8 M 53 Sunset 14 Convalescent phase BTM 8 mg 3 8 d
9 M 65 Sunset 17 Convalescent phase BTM 8 mg 3 8 d
10 M 62 Sunset 24 Convalescent phase BTM 8 mg 3 8 d
11 M 44 Sunset 27 Chronic/recurrence phase BTM 8 mg 3 7 d
12 M 75 Sunset 60 Convalescent phase BTM 8 mg 3 7 d
13 M 56 Sunset 132 Chronic/recurrence phase Unknown
14 F 81 Sunset 300 Chronic/recurrence phase Unknown
BTM, betamethasone; F, female; M, male.
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calculated to evaluate the depolarization or the polarization
scramble of the tissue.19 In our analyses, the DOPU with
Makita’s noise correction was computed by using a 3 pixel
(transverse) 3 3 pixel (depth) kernel.20 Composite DOPU B-
scan OCT images, in which the area of low DOPU (<0.8) was
overlaid on the standard OCT B-scan image with red color,
were created to specify the location of the depolarization
observed in the standard OCT image (Figs. 1G, 2G, 3G, 4D).
Standard B-scan OCT images were calculated by averaging four
sets of PS-OCT B-scan images.
For the objective evaluation of choroidal melanin, we
calculated the percentage area of low DOPU in the choroidal
interstitial stroma. First, the choroid area in the standard OCT
B-scan images was manually selected by a retina specialist
(MM). Binarization using the local Otsu method, followed by
median filtering, was applied for the standard OCT B-scan
images by using image processing software (Fiji21) to separate
the choroidal area into vessel and interstitial area (Figs. 1H, 2H,
3H, 4E). The percentage area of low DOPU (<0.8), which is
the occupancy of the low DOPU area within the choroidal
interstitial stroma, was calculated from the B-scan DOPU
images (Figs. 1I, 2I, 3I, 4F). For each eye, the percentage area of
low DOPU was calculated by using the mean of three
horizontal B-scan images (e.g., foveal B-scan, 3 mm above the
fovea and 3 mm below the fovea; Fig. 5). To determine the
repeatability, we evaluated the percentage area of low DOPU
for 10 eyes from 10 participants in the control group (9 males,
1 female; age range, 30–69 years; mean age, 47.9 years; 8 right
eyes and 2 left eyes). The coefficient of variation was
calculated by four repeated measurements for each participant.
Multimodal Imaging
For multimodal imaging, near-infrared (NIR; 817 nm) images,
near-infrared autofluorescence (NIR-AF; 785 nm excitation,
FIGURE 1. Multimodal imaging of the right eye of a 54-year-old female from the control group. The white line in the CF image (A) designates the
scan line of the PS-OCT B-scan image (E–I). Neither the NIR image (B), NIR-AF image (C), SW-AF image (D), nor standard OCT B-scan image (E)
provides information about the melanin density in the choroid. The DOPU B-scan image (F) and composite DOPU B-scan OCT image (G) show the
melanin distribution in the RPE and choroid. Binarization was applied for the standard OCT B-scan image to detect the choroidal interstitial area (H)
and red lines indicate manually segmented lines of the choroid (H). The red lines in the B-scan image for the calculation of percentage area of low
DOPU (I) show the boundary of the choroidal interstitial stroma. The scale bar in B-scan images represents 500 lm3 500 lm.
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emission > 800 nm) images, and short-wavelength autofluo-
rescence (SW-AF; 488 nm excitation, emission > 500 nm)
images were obtained with the confocal scanning laser
ophthalmoscope (HRA2; Heidelberg Engineering, Heidelberg,
Germany). Square images with side lengths of 308 (768 pixels)
were saved in an 8-bit grayscale. CF images with a 508 (1100
pixels) visual angle were captured with a Topcon TRC50IX
retinal camera (Topcon, Tokyo, Japan). From captured CF
images, square images with side lengths of 308 (660 pixels)
around the fovea were clipped for subjective evaluation (Fig.
5). Using CF, NIR, NIR-AF, and SW-AF images, each eye was
individually evaluated by two blinded observers (RT, TA) in
terms of the presence of an SGF. In the case of discrepancies, a
third observer (TI) acted as a referee and helped reach a
consensus. From subjective evaluations with CF images, the
eyes with VKH disease were classified by the presence (sunset
group) or absence (non-sunset group) of the SGF.
For the objective evaluation of the color balance in the CF
images without optic disc or peripapillary atrophy, square
images with side lengths of 300 pixels were prepared.
According to the image analysis software (IMAGEnet; Topcon),
this equated to approximately 6 mm around the fovea (Fig. 5).
Three-color channel luminance histograms on a 256-step scale
were measured with image processing software (Fiji21). In this
study, we calculated the SGI in the same mean with previous
studies as follows7,22,23:
SGI ¼ Lred

Lred þ Lgreen þ Lblue
 
;
where Lred was the mean luminance of the red channel, Lgreen
was the mean luminance of the green channel, and Lblue was
the mean luminance of blue channel. The SGI was calculated
for eyes in the sunset, non-sunset, control, and tessellated
fundus groups.
FIGURE 2. Multimodal imaging from the right eye of a 45-year-old male (case 7) from the sunset group. The white line in the CF image (A) indicates
the scan line of the PS-OCT B-scan image (E–I). Neither the NIR image (B), NIR-AF image (C), SW-AF image (D), nor standard OCT B-scan image (E)
provides information about melanin density in the choroid. The DOPU B-scan image (F) and composite DOPU B-scan OCT image (G) show the
disappearance of choroidal melanin. The red lines in the binary image indicate the segmentation line of the choroid (H). The red lines in the B-scan
image for the calculation of percentage area of low DOPU (I) show the boundary of the choroidal interstitial stroma. The scale bar in B-scan images
represents 500 lm 3 500 lm.
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For subfoveal choroidal thickness measurements, the
choroid area in standard OCT B-scan images was defined as
the layer between the RPE and the choroidoscleral interface in
standard OCT B-scan images. The subfoveal choroidal thick-
ness was manually measured with image processing software
(Fiji21) for all eyes.
RESULTS
In control eyes, the standard OCT B-scan images showed the
location of the choroid and RPE but did not provide
information about the distribution of melanin (Fig. 1E). En
face images, including CF, NIR, NIR-AF, and SW-AF, did not
provide isolated information about the choroidal melanin (Figs.
1A–D). In contrast, when the PS-OCT data were plotted as
pseudocolors in cross-sectional images of DOPU, there were
focal color changes that emphasized depolarization consistent
with melanin at the RPE and choroid (Fig. 1F). The choroidal
melanin location was then determined with the composite
DOPU B-scan OCT images (Fig. 1G).
According to subjective evaluation of CF images for the
VKH group, 16 eyes from eight patients (seven males, one
female; age range, 44–81 years; mean age, 60.1 years) were
grouped into the sunset group and 12 eyes from six
participants (one male, five females; age range, 39–82 years;
mean age, 61.5 years) were grouped into the non-sunset group.
Standard OCT B-scan images did not show clear differences
between the sunset and non-sunset groups (Figs. 2E, 3E).
DOPU B-scan OCT images clearly showed the absence of
choroidal melanin in eyes from the sunset group (Figs. 2F, 2G)
and the presence of choroidal melanin in the non-sunset group
(Figs. 3F, 3G). There was no apparent difference in background
reflectance in the NIR, NIR-AF, or SW-AF images between the
sunset and non-sunset groups (Figs. 2B–D, 3B–D). Regarding
the subjective evaluation by the graders, the concordance
FIGURE 3. Multimodal imaging from the left eye of a 45-year-old female (case 6) from the non-sunset group. The white line in the CF image (A)
indicates the scan line of the PS-OCT B-scan image (E–I). Neither the NIR image (B), NIR-AF image (C), SW-AF image (D), nor standard OCT B-scan
image (E) provides information about melanin density in the choroid. The DOPU B-scan image (F) and composite DOPU B-scan OCT image (G)
show the melanin distribution in the RPE and choroid. The red lines in the binary image indicate the segmentation line of the choroid (H). The red
lines in the B-scan image for the calculation of the percentage area of low DOPU (I) show the boundary of the choroidal interstitial stroma. The
scale bar in B-scan images represents 500 lm3 500 lm.
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percentages (j values) with the CF images were 0.220, 0.145,
and 0.037 for NIR, NIR-AF, and SW-AF images, respectively. The
j values of interobserver agreement (RT, TA) were 1.000,
1.000, 0.364, and 1.000 for the CF, NIR, NIR-AF, and SW-AF
images, respectively. In eyes of the tessellated fundus group, CF
images with tessellated fundus appearance showed a bright
orange background color, similar to the SGF appearance (Fig.
4A). Standard B-scan OCT images showed choroidal thinning
(Fig. 4B), and composite DOPU B-scan OCT images clearly
showed the presence of melanin in the choroid (Fig. 4D).
Area percentages of low DOPU in the choroidal interstitial
stroma (mean 6 SD [range]) were 0.005 6 0.004 (0.0002–
0.014), 0.303 6 0.139 (0.091–0.576), 0.327 6 0.153 (0.113–
0.573), and 0.254 6 0.136 (0.108–0.598) for the sunset, non-
FIGURE 4. PS-OCT imaging from the left eye of a 60-year-old female from the tessellated fundus group. The white line in the CF image (A) indicates
the scan line of the PS-OCT B-scan image (B–F). The standard OCT B-scan image (B) shows choroidal thinning. The DOPU B-scan image (C) and
composite DOPU B-scan OCT image (D) show the presence of choroidal melanin. The red lines in the binary image indicate the segmentation line
of the choroid (E). The red lines in the B-scan image for the calculation of the percentage area of low DOPU (F) show the boundary of the choroidal
interstitial stroma. The scale bar in B-scan images represents 500 lm3 500 lm.
FIGURE 5. Measurement area in a CF image of the left eye of case 6.
The black line designates the area for subjective evaluation (3083308).
The white line designates the area for the SGI measurement (3003300
pixels). The yellow lines designate the scan lines of the PS-OCT B-scan
images for the measurement of the percentage area of low DOPU.
FIGURE 6. The distribution of percentage areas of low DOPU in the
choroidal interstitial stroma in the sunset, non-sunset, control, and
tessellated fundus groups. *P < 0.001.
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sunset, control, and tessellated fundus groups, respectively.
The mean percentage area of low DOPU in the sunset group
was significantly lower than that of the other groups (P <
0.001; Kruskal-Wallis test; Mann-Whitney U test) and showed
no overlap with the other groups (Fig. 6). The coefficient of
variation using four repeated measurements (mean 6 SD) was
0.16 6 0.04. The percentage areas of low DOPU did not show
significant correlations with age for any of the groups (R2 ¼
0.12, P¼ 0.19 for the sunset group; R2¼ 0.24, P¼ 0.10 for the
non-sunset group; R2¼ 0.09, P¼ 0.20 for the control group; R2
¼ 0.04, P ¼ 0.35 for the tessellated fundus group; Pearson’s
correlation; Fig. 7).
The SGI (mean 6 SD [range]) in the CF images was 0.649 6
0.049 (0.565–0.723), 0.578 6 0.046 (0.500–0.637), 0.550 6
0.043 (0.465–0.645), and 0.641 6 0.038 (0.561–0.706) in the
sunset, non-sunset, control, and tessellated fundus groups,
respectively. The mean SGI in the sunset and tessellated fundus
groups was significantly larger than that of the other groups (P
¼ 0.022 for sunset and P < 0.001 for tessellated fundus;
Kruskal-Wallis test; Mann-Whitney U test). The distribution of
the SGI in the sunset group substantially overlapped with the
other groups (Fig. 8A). In the eyes with VKH disease, the SGI
did show a significant negative correlation with the percentage
areas of low DOPU for both the sunset and non-sunset group
(R2¼0.21, P¼0.043 for the sunset group; R2¼0.34, P¼0.045
for the non-sunset group; Pearson’s correlation; Fig. 9).
Subfoveal choroidal thicknesses (mean 6 SD [range]) were
172 6 78 lm (22–328), 256 6 70 lm (140–346), 237 6 76 lm
(108–385), and 48 6 19 lm (21–86) for the sunset, non-sunset,
control, and tessellated fundus groups, respectively. The mean
FIGURE 7. Scatterplots illustrating the relationship between the age of the subjects and the mean percentage area of low DOPU in the sunset (A),
non-sunset (B), control (C), and tessellated fundus (D) groups.
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subfoveal choroidal thickness in the tessellated fundus group
was significantly smaller than that of the other groups (P <
0.001; Kruskal-Wallis test; Mann-Whitney U test). The mean
subfoveal choroidal thickness in the sunset group was
significantly smaller than that of the non-sunset or control
groups (P ¼ 0.022; Kruskal-Wallis test; Mann-Whitney U test).
The distribution of the subfoveal choroidal thickness in the
sunset group substantially overlapped with the other groups
(Fig. 8B). In the VKH group, the subfoveal choroidal thickness
did not show a significant correlation with the percentage area
of low DOPU for either the sunset or non-sunset groups (R2¼
0.004, P¼0.82 for the sunset group; R2¼0.13, P¼0.13 for the
non-sunset group; Pearson’s correlation; Fig. 10).
DISCUSSION
Despite the importance of the SGF appearance for the
diagnosis of chronic VKH disease,4 there are no established
objective methods to confirm its existence. In the present
study, the disappearance of choroidal melanin in eyes with an
SGF was confirmed with PS-OCT. Other imaging modalities,
including standard OCT, NIR, NIR-AF, or SW-AF, were not useful
in providing specific findings to support the SGF changes.
In normal chorioretinal tissue, melanin is found in RPE cells
and choroidal melanocytes.24 In this study, DOPU B-scan
images in control eyes clearly showed the presence of melanin
in both the RPE and choroid. In contrast, eyes with an SGF
showed the disappearance of choroidal melanin and the
preservation of RPE melanin. Histopathologic studies of the
SGF show the disappearance of choroidal melanocytes with
mild inflammatory cell infiltration, with relative sparing of the
overlying RPE.2,3 In vivo PS-OCT findings confirmed these
histopathologic changes.
Suzuki7 has suggested the use of the SGI for the objective
evaluation of color balance in CF images, and an increase in the
SGI suggested aggravation of the SGF. In the present study, the
percentage area of low DOPU in VKH disease showed a
negative correlation with the SGI. Using PS-OCT, the low
DOPU in the choroid was thought to result from depolarization
of melanin particles.14 Hence, the percentage area of the low
FIGURE 8. (A) The distribution of the sunset glow index in the sunset,
non-sunset, control, and tessellated fundus groups. *P ¼ 0.022, **P <
0.001. (B) The distribution of subfoveal choroidal thickness in the
sunset, non-sunset, control, and tessellated fundus groups. *P¼ 0.015,
**P ¼ 0.022, ***P < 0.001
FIGURE 9. Scatterplots of the sunset glow index and mean percentage area of low DOPU in the sunset (A) and non-sunset (B) groups. Black lines
show the regression line of the correlation in the sunset (A) and non-sunset (B) groups.
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DOPU in the choroidal interstitial stroma could be used as an
objective index of choroidal melanin. The correlation of the
percentage area of low DOPU with the SGI in the VKH group
suggested that PS-OCT measurements can be used as an
objective parameter for the development of the SGF. However,
the discriminatory ability of the SGI was lower than that of PS-
OCT imaging and involved a substantial overlap between the
sunset group and other groups. Consistency of color balance is
frequently affected by sensor characteristics, spatial resolution,
file compression, color management, exposure, saturation,
contrast, or a lack of universal standards.25,26 The retina
presents a narrow color gamut, compared with most other
scenes, and the red color channel might be frequently
saturated.25 Standardization of these parameters is therefore
necessary for the objective evaluation of the CF images.
Furthermore, the influence of RPE melanin might impair the
evaluation of choroidal melanin with CF images. In contrast,
DOPU B-scan images could be evaluated solely with choroidal
melanin, without the interference of RPE melanin. Hence, PS-
OCT imaging might be more reliable than CF imaging to
evaluate the SGF.
In this study, NIR, SW-AF, or NIR-AF did not show specific
findings for the SGF. Low concordance of these images with the
CF images showed a limited ability to evaluate the SGF. AF in
SW-AF imaging is thought to originate from lipofuscin in the
RPE.27 Our study supported the insensitive nature of SW-AF
imaging for choroidal melanin. AF in NIR-AF is thought to
originate from melanin in the RPE or choroidal melanocytes, or
melanin-containing inflammatory cells.28 In SGF, AF in NIR-AF
imaging might be decreased by the disappearance of choroidal
melanocytes. However, in this study, subjective evaluation with
NIR-AF showed substantial inconsistencies with the CF or PS-
OCT. One possible explanation is the relative sparing of
melanin in the RPE, which might conceal the AF signal from
the choroid. Another possibility is the difficulty in confirming
diffuse changes in the background AF because of a lack of
reference values in NIR-AF imaging. Further studies with
objective measurement of NIR-AF signals might be a possible
solution for these limitations.
In this study, subfoveal choroidal thickness decreased
significantly in the sunset group compared to the non-sunset
group. In the sunset group, chronic inflammation might have
induced tissue necrosis, fibrosis, and finally, choroidal thin-
ning.2,3 However, the discriminatory ability of SGF was limited
by substantial overlap with control or non-sunset groups.
Moreover, choroidal thickness did not show a significant
correlation with the PS-OCT. The distribution of normal
choroidal thickness was highly diverse compared to other
retinal OCT parameters, such as retinal thickness.29 Further-
more, there might be variations in the severities of choroidal
thickness reductions in an SGF. These factors might impede the
ability of choroidal thickness measurements to evaluate the
SGF. However, choroidal thickness in the tessellated fundus
group was significantly thinner than that of the sunset group.
DOPU B-scan OCT images in the tessellated fundus group
represented the retention of melanocytes despite choroidal
thinning. These findings indicated that the bright fundus color
in a tessellated fundus originates from the choroidal thinning,
not melanin disappearance.
This study had some limitations. With the relatively small
number of patients, our study evaluated only some aspects of
sunset glow appearance. To evaluate the development of the
SGF, a long-term observational study from the onset of the
intraocular inflammation is required. It should also be noted
that choroidal melanin content is affected by ethnic differenc-
es.30 Given that this study only evaluated Japanese patients,
future research projects should investigate whether our
findings extend to other ethnicities. Although a previous
histologic study has indicated that human choroidal melanin
tends to decrease with age,30 we did not observe in the present
study any significant correlation between the percentage area
of low DOPU and age in any of the groups. Furthermore,
although there is evidence that a monotonic relationship exists
between DOPU and melanin,14 the nature of this relationship
remains poorly understood and is seldom investigated. Larger
cohort studies are required to thoroughly evaluate the impact
of age on DOPU and melanin.
In conclusion, this study showed the clinical usefulness of
PS-OCT to evaluate the SGF in VKH disease. DOPU measure-
ment with PS-OCT could noninvasively evaluate choroidal
melanin content and may have the potential for the clinical
assessment of chronic VKH disease. However, PS-OCT is not
FIGURE 10. Scatterplots of the subfoveal choroidal thickness and mean percentage area of low DOPU in the sunset (A) and non-sunset (B) groups.
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yet commercially available for widespread use and mainte-
nance and operation of PS-OCT systems is more complicated
than for commercialized standard OCT. Further study is
necessary to confirm the possible use of PS-OCT for chronic
VKH disease.
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